Literature DB >> 11181455

Resveratrol analog, 3,4,5,4'-tetrahydroxystilbene, differentially induces pro-apoptotic p53/Bax gene expression and inhibits the growth of transformed cells but not their normal counterparts.

J Lu1, C H Ho, G Ghai, K Y Chen.   

Abstract

Resveratrol, a trihydroxystilbene found in grapes and other plants, has been shown to be active in inhibiting multistage carcinogenesis. Using resveratrol as a prototype, we have synthesized a number of polyhydroxy- and polymethoxy-stilbenes and tested their anti-proliferative effect in normal and transformed human cells. Here we show that one of the resveratrol analogs, 3,4,5,4'-tetrahydroxystilbene (R-4), specifically inhibited the growth of SV40 virally transformed WI38 cells (WI38VA) at 10 microM, but had no effect on normal WI38 cells at even higher concentrations. R-4 also prominently induced apoptosis in WI38VA cells, but not in WI38 cells. RNase protection assay showed that R-4 significantly induced the expression of p53, GADD45 and Bax genes and concomitantly suppressed the expression of bcl-2 gene in WI38VA, but not in WI38 cells. A large increase in p53 DNA binding activity and the presence of p53 in the Bax promoter binding complex suggested that p53 was responsible for the Bax gene expression induced by R-4 in transformed cells. Within 4 h of treatment with R-4, the Bax to bcl-2 protein ratio in WI38 and WI38VA cells was, respectively, 0.1 and 105, a difference of three orders of magnitude. While R-4 prominently induced the p53/Bax pro-apoptotic genes, it also concomitantly suppressed the expression of Cox-2 in WI38VA cells. Taken together, our study suggests that the induction of p53 gene by R-4 in transformed cells may play a key role in the differential growth inhibition and apoptosis of transformed cells.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11181455     DOI: 10.1093/carcin/22.2.321

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  15 in total

1.  Resveratrol inhibits cell growth and induces apoptosis of rat C6 glioma cells.

Authors:  Wei Zhang; Zhou Fei; Hai-Ning Zhen; Jian-Ning Zhang; Xiang Zhang
Journal:  J Neurooncol       Date:  2006-09-20       Impact factor: 4.130

2.  Targeting host nucleotide biosynthesis with resveratrol inhibits emtricitabine-resistant HIV-1.

Authors:  Alonso Heredia; Charles Davis; Mohammed N Amin; Nhut M Le; Mark A Wainberg; Maureen Oliveira; Steven G Deeks; Lai-Xi Wang; Robert R Redfield
Journal:  AIDS       Date:  2014-01-28       Impact factor: 4.177

3.  The resveratrol analogue 3,5,3',4',5'-pentahydroxy-trans-stilbene inhibits cell transformation via MEK.

Authors:  Ki Won Lee; Nam Joo Kang; Evgeny A Rogozin; Sang-Muk Oh; Yong Seok Heo; Angelo Pugliese; Ann M Bode; Hyong Joo Lee; Zigang Dong
Journal:  Int J Cancer       Date:  2008-12-01       Impact factor: 7.396

4.  Xenohormetic and anti-aging activity of secoiridoid polyphenols present in extra virgin olive oil: a new family of gerosuppressant agents.

Authors:  Javier A Menendez; Jorge Joven; Gerard Aragonès; Enrique Barrajón-Catalán; Raúl Beltrán-Debón; Isabel Borrás-Linares; Jordi Camps; Bruna Corominas-Faja; Sílvia Cufí; Salvador Fernández-Arroyo; Anabel Garcia-Heredia; Anna Hernández-Aguilera; María Herranz-López; Cecilia Jiménez-Sánchez; Eugeni López-Bonet; Jesús Lozano-Sánchez; Fedra Luciano-Mateo; Begoña Martin-Castillo; Vicente Martin-Paredero; Almudena Pérez-Sánchez; Cristina Oliveras-Ferraros; Marta Riera-Borrull; Esther Rodríguez-Gallego; Rosa Quirantes-Piné; Anna Rull; Laura Tomás-Menor; Alejandro Vazquez-Martin; Carlos Alonso-Villaverde; Vicente Micol; Antonio Segura-Carretero
Journal:  Cell Cycle       Date:  2013-01-31       Impact factor: 4.534

5.  Targeting of the purine biosynthesis host cell pathway enhances the activity of tenofovir against sensitive and drug-resistant HIV-1.

Authors:  Alonso Heredia; Charles E Davis; Marvin S Reitz; Nhut M Le; Mark A Wainberg; James S Foulke; Lai-Xi Wang; Robert R Redfield
Journal:  J Infect Dis       Date:  2013-08-06       Impact factor: 5.226

Review 6.  Resveratrol in cell fate decisions.

Authors:  Andrea Lisa Holme; Shazib Pervaiz
Journal:  J Bioenerg Biomembr       Date:  2007-02       Impact factor: 3.853

7.  Role of Bax in resveratrol-induced apoptosis of colorectal carcinoma cells.

Authors:  Mojgan Mahyar-Roemer; Hans Köhler; Klaus Roemer
Journal:  BMC Cancer       Date:  2002-10-17       Impact factor: 4.430

8.  Pharmacokinetics in mice and growth-inhibitory properties of the putative cancer chemopreventive agent resveratrol and the synthetic analogue trans 3,4,5,4'-tetramethoxystilbene.

Authors:  S Sale; R D Verschoyle; D Boocock; D J L Jones; N Wilsher; K C Ruparelia; G A Potter; P B Farmer; W P Steward; A J Gescher
Journal:  Br J Cancer       Date:  2004-02-09       Impact factor: 7.640

9.  A methoxy derivative of resveratrol analogue selectively induced activation of the mitochondrial apoptotic pathway in transformed fibroblasts.

Authors:  A Gosslau; M Chen; Ci-T Ho; K Y Chen
Journal:  Br J Cancer       Date:  2005-02-14       Impact factor: 7.640

10.  SIRT1 activation enhances HDAC inhibition-mediated upregulation of GADD45G by repressing the binding of NF-κB/STAT3 complex to its promoter in malignant lymphoid cells.

Authors:  A Scuto; M Kirschbaum; R Buettner; M Kujawski; J M Cermak; P Atadja; R Jove
Journal:  Cell Death Dis       Date:  2013-05-16       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.